Skip to main content

Table 4 Description of adverse events in each group.

From: Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trial

 

N

minoxidil

N

placebo

Withdrawal from treatment

9

1

12

0

Withdrawal from treatment because of adverse events

9

1

12

0

Serious Adverse events*

9

1

12

1

Any adverse events

9

8

12

11

Hypertrichosis

9

5

12

0

  1. *: not related to the treatment (flat foot and strabism correction)